Rights and permissions
About this article
Cite this article
Delayed-release mesalazine provides sustained efficacy in UC. Inpharma Wkly. 1661, 14 (2008). https://doi.org/10.2165/00128413-200816610-00040
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816610-00040